`
`AO 120 (Rev. 08/10
`
`TO:
`
`Mail Stop 8
`Director of the U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`REPORT ON THE
`FILING OR DETERMINATION OF AN
`ACTION REGARDING A PATENT OR
`TRADEMARK
`
`In Compliance with 35 U.S.C. § 290 and/or 15 U.S.C. § 1116 you are hereby advised that a court action has been
`for the Northern District of West Virginia (cid:9)
`on the following
`filed in the U.S. District Court (cid:9)
`gr Patents. ( LI the patent action involves 35 U.S.C. § 292.):
`LI Trademarks or (cid:9)
`
`DOCKET NO.
`
`PLAINTIFF
`
`DATE FILED
`10/30/2018
`
`U.S. DISTRICT COURT
`for the Northern District of West Virginia
`DEFENDANT
`
`Anacor Pharmaceuticals, Inc.
`
`Mylan Pharmaceuticals Inc., Mylan Inc.
`
`_
`
`PATENT OR
`TRADEMARK NO.
`
`DATE OF PATENT
`OR TRADEMARK
`
`HOLDER OF PATENT OR TRADEMARK
`— --
`
`1 (cid:9) 9,459,938
`
`2 (cid:9) 9,566,289
`
`3 (cid:9) 9,566,290
`
`4 9,572,823
`
`5
`
`1/24/2017
`
`2/14/2017
`
`2/14/2017
`
`2/21/2017
`
`Anacor Pharmaceuticals, Inc. (cid:9)
`
`Anacor Pharmaceuticals, Inc. (cid:9)
`
`Anacor Pharmaceuticals, Inc.
`
`Anacor Pharmaceuticals, Inc.
`
`FILED
`
`OCT 202018
`
`U.S. DISTRICT nOURT
`WHEELING, WV 26C
`
`In the above—entitled case, the following patent(s)/ trademark(s) have been included:
`
`DATE INCLUDED
`
`INCLUDED BY
`
`PATENT OR
`TRADEMARK NO.
`
`II Amendment (cid:9)
`DATE OF PATENT
`OR TRADEMARK
`
`• Answer (cid:9)
`
`III Cross Bill (cid:9)
`
`E Other Pleading
`
`HOLDER OF PATENT OR TRADEMARK
`
`I
`
`2
`
`3
`
`4
`
`5
`
`In the above—entitled case, the following decision has been rendered or judgement issued:
`
`DECISION/JUDGEMENT
`
`CLERK
`
`(BY) DEPUTY CLERK
`
`DATE
`
`Copy 1—Upon initiation of action, mail this copy to Director Copy 3—Upon termination of action, mail this copy to Director
`Copy 2—Upon filing document adding patent(s), mail this copy to Director Copy 4—Case file copy
`
`